NASDAQ:ASNS - Arsanis Stock Price, Forecast & News

Arsanis trades on the NASDAQ under the ticker symbol "ASNS."

Arsanis Inc (NASDAQ:ASNS) released its earnings results on Friday, November, 9th. The company reported ($0.76) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.74) by $0.02. View Arsanis' Earnings History.

News coverage about ASNS stock has trended neutral on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Arsanis earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near term. View News Stories for Arsanis.

Some companies that are related to Arsanis include Shield Therapeutics (STX), Tristel (TSTL), Kezar Life Sciences (KZR), TELA Bio (TELA), Probiotec (PBP), Strongbridge Biopharma (SBBP), Green Organic Dutchman (TGOD), Neptune Wellness Solutions (NEPT), NuCana (NCNA), Antibe Therapeutics (ATE), Helix Biopharma (HBP), Avenue Therapeutics (ATXI), Fennec Pharmaceuticals (FRX), Spero Therapeutics (SPRO) and Pulse Biosciences (PLSE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Arsanis investors own include Catalyst Pharmaceuticals (CPRX), Nektar Therapeutics (NKTR), NxStage Medical (NXTM), Selecta Biosciences (SELB), CDTi Advanced Materials (CDTI), Axsome Therapeutics (AXSM), Curis (CRIS), Inovio Pharmaceuticals (INO), Progenics Pharmaceuticals (PGNX) and Portola Pharmaceuticals (PTLA).

(ASNS) raised $50 million in an initial public offering on Thursday, November 16th 2017. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Citigroup, Cowen and Piper Jaffray served as the underwriters for the IPO.

One share of ASNS stock can currently be purchased for approximately $3.11.

Arsanis has a market capitalization of $45.53 million and generates $3.50 million in revenue each year. The company earns $-33,870,000.00 in net income (profit) each year or ($16.23) on an earnings per share basis. View Additional Information About Arsanis.

The official website for Arsanis is http://www.arsanis.com/.

Arsanis' mailing address is 890 WINTER STREET SUITE 230, WALTHAM MA, 02451. The company can be reached via phone at 781-819-5704 or via email at [email protected]